143 related articles for article (PubMed ID: 37260888)
1. Clinical investigation of use of Episil® oral solution in oral mucositis during radiotherapy for head and neck cancer.
Ito K; Tokura S; Takazawa I; Yoshida N; Nakanishi T; Akiyama K; Onuma Y; Adachi T; Harada H; Nojima H; Miura M; Yoshimura R; Kabasawa Y
Heliyon; 2023 Jun; 9(6):e15869. PubMed ID: 37260888
[TBL] [Abstract][Full Text] [Related]
2. A Bioadhesive Barrier-Forming Oral Liquid Gel Improved Oral Mucositis and Nutritional Status in Patients With Head and Neck Cancers Undergoing Radiotherapy: A Retrospective Single Center Study.
Wei J; Wu J; Wang H; Wang B; Zhao T; Meng L; Dong L; Jiang X
Front Oncol; 2021; 11():617392. PubMed ID: 33692954
[TBL] [Abstract][Full Text] [Related]
3. Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study.
Ueno T; Yatsuoka W; Ishiki H; Miyano K; Uezono Y
BMC Cancer; 2022 Jan; 22(1):90. PubMed ID: 35062896
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Episil® in patients with hematologic malignancies: a comparative study.
Fukutani T; Yoshioka Y; Imori S; Yanagihara H; Sumi K; Myoken Y; Fujita Y; Yanamoto S
BMC Oral Health; 2024 May; 24(1):522. PubMed ID: 38698387
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T
Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of Acute Radiation Dermatitis in Breast Cancer Patients by a Bioadhesive Barrier-Forming Gel (Episil): A Single-Center, Open, Parallel, Randomized, Phase I/II Controlled Trial.
Li Q; Feng S; Yu Z; Wang Y; Tian L; Geng H; Guo C; Ning F; Luo J; Liu C
Clin Pharmacol Ther; 2024 May; 115(5):1085-1091. PubMed ID: 38159264
[TBL] [Abstract][Full Text] [Related]
8. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
[TBL] [Abstract][Full Text] [Related]
9. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
[TBL] [Abstract][Full Text] [Related]
10. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
11. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
12. The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors.
Liu M; An R; Wu Z; Dai L; Zeng Q; Chen W
Ear Nose Throat J; 2024 Feb; ():1455613241228211. PubMed ID: 38334289
[TBL] [Abstract][Full Text] [Related]
13. Pain management in patients undergoing radiation therapy for head and neck cancer - a descriptive study.
Schaller AKCS; Peterson A; Bäckryd E
Scand J Pain; 2021 Apr; 21(2):256-265. PubMed ID: 34387952
[TBL] [Abstract][Full Text] [Related]
14. A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients.
Taylor JK; Mady LJ; Baddour K; Iheagwara UK; Zhai S; Ohr JP; Zandberg DP; Gorantla VC; Ferris RL; Kim S; Duvvuri U; Kubik MW; Sridharan S; Johnson JT; Holeva KD; Quinn AE; Clump DA
World J Otorhinolaryngol Head Neck Surg; 2022 Dec; 8(4):345-354. PubMed ID: 36474663
[TBL] [Abstract][Full Text] [Related]
15. A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol.
Morais MO; Martins AFL; de Jesus APG; de Sousa Neto SS; da Costa AWF; Pereira CH; Oton-Leite AF; de Freitas NMA; Leles CR; Mendonça EF
Support Care Cancer; 2020 Sep; 28(9):4263-4273. PubMed ID: 31900618
[TBL] [Abstract][Full Text] [Related]
16. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
[TBL] [Abstract][Full Text] [Related]
17. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes.
Dodd MJ; Miaskowski C; Greenspan D; MacPhail L; Shih AS; Shiba G; Facione N; Paul SM
Cancer Invest; 2003; 21(1):21-33. PubMed ID: 12643006
[TBL] [Abstract][Full Text] [Related]
19. Oral Glutamine May Have No Clinical Benefits to Prevent Radiation-Induced Oral Mucositis in Adult Patients With Head and Neck Cancer: A Meta-Analysis of Randomized Controlled Trials.
Shuai T; Tian X; Xu LL; Chen WQ; Pi YP; Zhang L; Wan QQ; Li XE
Front Nutr; 2020; 7():49. PubMed ID: 32363198
[No Abstract] [Full Text] [Related]
20. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Guddattu V
J Photochem Photobiol B; 2015 Mar; 144():51-6. PubMed ID: 25704314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
